Finnish population-based study: Vulnerable groups were the least likely to uptake COVID-19 vaccination helsinkiuni NatureHumBehav
. Clinical endpoints were collected between 1 January 1969 and 31 December 2019.
. Missing income information was treated as a separate binary predictor. There are multiple reasons why income information might be missing, including unemployment, severe illness and retirement.Information about education level and field of education was retrieved from Statistics Finland as the highest completed degree by statistical year. The data exist for 1970, 1975, 1985 and every year between 1987 and 2018.
In this study, we used these data to create two sets of binary predictors. The first set contains 20 predictors that detail the type of care given to an individual . The second set contains 29 predictors that describe the main reason for entering the treatment. In addition, we created a predictor describing whether an individual had any periods of long-term care between 1995 and 2019 and another predictor to sum up the total number of treatment days within the same period.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Emergency alert test warning issued as drivers face £200 fine for breaking lawDrivers warned not to touch phones during emergency alert test as they face £200 fine for breaking law
Weiterlesen »
Royals take surprise booking during Birmingham restaurant visitThe prince and princess visit Birmingham as part of a nationwide tour ahead of the coronation.
Weiterlesen »
Previous BCG vaccination is associated with less severe clinical progression of COVID-19 - BMC MedicineBackground BCG vaccination, originally used to prevent tuberculosis, is known to “train” the immune system to improve defence against viral respiratory infections. We investigated whether a previous BCG vaccination is associated with less severe clinical progression of COVID-19 Methods A case-control study comparing the proportion with a BCG vaccine scar (indicating previous vaccination) in cases and controls presenting with COVID-19 to health units in Brazil. Cases were subjects with severe COVID-19 (O2 saturation | 90%, severe respiratory effort, severe pneumonia, severe acute respiratory syndrome, sepsis, and septic shock). Controls had COVID-19 not meeting the definition of “severe” above. Unconditional regression was used to estimate vaccine protection against clinical progression to severe disease, with strict control for age, comorbidity, sex, educational level, race/colour, and municipality. Internal matching and conditional regression were used for sensitivity analysis. Results BCG was associated with high protection against COVID-19 clinical progression, over 87% (95% CI 74–93%) in subjects aged 60 or less and 35% (95% CI − 44–71%) in older subjects. Conclusions This protection may be relevant for public health in settings where COVID-19 vaccine coverage is still low and may have implications for research to identify vaccine candidates for COVID-19 that are broadly protective against mortality from future variants. Further research into the immunomodulatory effects of BCG may inform COVID-19 therapeutic research.
Weiterlesen »
Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing supportIn a recent study published in the journal JAMA Network Open, researchers examined the clinical use of dexamethasone for hospitalized patients with coronavirus disease 2019 (COVID-19) respiratory illness and explored the heterogeneity of treatment outcomes across different subgroups.
Weiterlesen »
Observational cohort study of long COVID among 2 million elderly adultsResearch estimates the incidence of long COVID and long Flu among Medicare patients using the World Health Organization (WHO) consensus definition. The study compares the incidence, symptomatology, and healthcare utilization between long COVID and long flu patients.
Weiterlesen »
'Healthy' doctor, 32, died after rare severe reaction to AstraZeneca COVID jab, coroner concludesDr Stephen Wright, of Sevenoaks, Kent, was one of a small number of people to have had a severe reaction to the jab in what the coroner described as a 'very unusual and deeply tragic case'.
Weiterlesen »